OVERVIEW
COMMITMENT TO INNOVATION
WATCHMAN LAAC DEVICE
TAVI PORTFOLIO
CLINICAL EVIDENCE

CLINICAL EVIDENCE


We are committed to advancing the clinical science behind our structural heart therapies in order to provide evidence for physicians and patients around the world.
ACURATE neo™ AORTIC VALVE SYSTEM

ACURATE neo


The ACURATE neo  Aortic Valve System offers an intuitive procedure, predictable release, stable positioning, and has demonstrated excellent clinical outcomes from a self-expanding, supra-annular valve technology.
ACURATE has demonstrated the lowest new permanent pacemaker rate in TAVI (1) (1)Real-world experience using a 2nd generation self-expanding prosthesis 1-year outcomes of 1000 patients enrolled in the SAVI TF registry: Prof Dr. H. Moellmann.
LOTUS Edge™ AORTIC VALVE SYSTEM

LOTUS Edge*


The LOTUS Edge Valve System is a mechanically expanding valve platform designed for full repositioning and retrievability, precise placement, freedom from PVL, predictable results, and complete control.
REPRISE III First Head-to-Head US Pivotal TAVR Trial

REPRISE III: First Head-to-Head US Pivotal TAVR Trial

EvolutR® / CoreValve®

SAFARI2™ PRE-SHAPED TAVI GUIDEWIRE
SAFARI2™ PRE-SHAPED TAVI GUIDEWIRE

SAFARI2™ Pre-shaped
Guidewire


Enables safe treatment of a broad range of patients with valvular disease.
Join our community to receive updates and help us advance the treatment of structural heart therapies.

BE A PART OF OUR VISION


We take partnership to heart. 
Join our community to receive updates and help us advance the treatment of structural heart therapies.
Top